Rezultati - David Cosgrove

Refine Results
  1. 1
    Management of perihilar cholangiocarcinoma in the era of multimodal therapy

    Management of perihilar cholangiocarcinoma in the era of multimodal therapy od Vicente Valero, David Cosgrove, Joseph M. Herman, Timothy M. Pawlik

    Izdano 2012
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    Pattern of distant metastases in colorectal cancer: a SEER based study

    Pattern of distant metastases in colorectal cancer: a SEER based study od Miao‐Zhen Qiu, Jian-Ming Hu, Dajun Yang, David Cosgrove, Rui‐Hua Xu

    Izdano 2015
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    Phase II Trial of Sorafenib Combined With Concurrent Transarterial Chemoembolization With Drug-Eluting Beads for Hepatocellular Carcinoma

    Phase II Trial of Sorafenib Combined With Concurrent Transarterial Chemoembolization With Drug-Eluting Beads for Hepatocellular Carcinoma od Timothy M. Pawlik, Diane K. Reyes, David Cosgrove, Ihab R. Kamel, Nikhil Bhagat, Jean-François H. Geschwind

    Izdano 2011
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management

    Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management od Kelly J. Lafaro, David Cosgrove, Jean-François H. Geschwind, Ihab R. Kamel, Joseph M. Herman, Timothy M. Pawlik

    Izdano 2015
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    Infiltrating Hepatocellular Carcinoma: Seeing the Tree through the Forest

    Infiltrating Hepatocellular Carcinoma: Seeing the Tree through the Forest od Aram N. Demirjian, Peter D. Peng, Jean-François H. Geschwind, David Cosgrove, Jacob Schutz, Ihab R. Kamel, Timothy M. Pawlik

    Izdano 2011
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  6. 6
    Emerging Approaches in the Management of Patients with Neuroendocrine Liver Metastasis: Role of Liver-Directed and Systemic Therapies

    Emerging Approaches in the Management of Patients with Neuroendocrine Liver Metastasis: Role of Liver-Directed and Systemic Therapies od Skye C. Mayo, Joseph M. Herman, David Cosgrove, Nik Bhagat, Ihab R. Kamel, Jean-François H. Geschwind, Timothy M. Pawlik

    Izdano 2012
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  7. 7
    Referral Patterns and Treatment Choices for Patients with Hepatocellular Carcinoma: A United States Population-Based Study

    Referral Patterns and Treatment Choices for Patients with Hepatocellular Carcinoma: A United States Population-Based Study od Omar Hyder, Rebecca M. Dodson, Hari Nathan, Joseph M. Herman, David Cosgrove, Ihab R. Kamel, Jean-François H. Geschwind, Timothy M. Pawlik

    Izdano 2013
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  8. 8
    Treatment and Prognosis of Patients with Fibrolamellar Hepatocellular Carcinoma: A National Perspective

    Treatment and Prognosis of Patients with Fibrolamellar Hepatocellular Carcinoma: A National Perspective od Skye C. Mayo, Michael N. Mavros, Hari Nathan, David Cosgrove, Joseph M. Herman, Ihab R. Kamel, Robert A. Anders, Timothy M. Pawlik

    Izdano 2013
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  9. 9
    Association Between Specific Mutations in<i>KRAS</i>Codon 12 and Colorectal Liver Metastasis

    Association Between Specific Mutations in<i>KRAS</i>Codon 12 and Colorectal Liver Metastasis od Georgios Antonios Margonis, Yuhree Kim, Gaya Spolverato, Aslam Ejaz, Rohan Gupta, David Cosgrove, Robert A. Anders, Georgios Karagkounis, Michael A. Choti, Timothy M. Pawlik

    Izdano 2015
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  10. 10
    Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours

    Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours od Devalingam Mahalingam, George Wilding, Samuel R. Denmeade, J. Sarantopoulas, David Cosgrove, Jeremy Cetnar, Nilofer S. Azad, Justine Y. Bruce, Michael R. Kurman, Victoria Allgood, Michael A. Carducci

    Izdano 2016
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  11. 11
    Atezolizumab Plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma: Real-World Experience From a US Community Oncology Network

    Atezolizumab Plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma: Real-World Experience From a US Community Oncology Network od David Cosgrove, Ruoding Tan, Andrew J. Osterland, Sairy Hernandez, Sarika Ogale, Sami Mahrus, John Murphy, Thomas W. Wilson, Gregory Patton, Arturo Loaiza‐Bonilla, Amit G. Singal

    Izdano 2025
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  12. 12
    Impact of Sarcopenia on Outcomes Following Intra-arterial Therapy of Hepatic Malignancies

    Impact of Sarcopenia on Outcomes Following Intra-arterial Therapy of Hepatic Malignancies od Rebecca M. Dodson, Amin Firoozmand, Omar Hyder, Vania Tacher, David Cosgrove, Nikhil Bhagat, Joseph M. Herman, Christopher L. Wolfgang, Jean-François H. Geschwind, Ihab R. Kamel, Timothy M. Pawlik

    Izdano 2013
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  13. 13
    Impact of a Single-Day Multidisciplinary Clinic on the Management of Patients with Liver Tumours

    Impact of a Single-Day Multidisciplinary Clinic on the Management of Patients with Liver Tumours od Jiangyang Zhang, Michail N. Mavros, David Cosgrove, Kenzo Hirose, Joseph M. Herman, S. Smallwood–Massey, Ihab R. Kamel, Ahmet Gürakar, Robert A. Anders, Andrew M. Cameron, J. Geschwind, Timothy M. Pawlik

    Izdano 2013
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  14. 14
    Chromophobe hepatocellular carcinoma with abrupt anaplasia: a proposal for a new subtype of hepatocellular carcinoma with unique morphological and molecular features

    Chromophobe hepatocellular carcinoma with abrupt anaplasia: a proposal for a new subtype of hepatocellular carcinoma with unique morphological and molecular features od Laura D. Wood, Christopher M. Heaphy, Hubert Darius-J Daniel, Bita V. Naini, Charles Lassman, May R. Arroyo, Ihab R. Kamel, David Cosgrove, John K. Boitnott, Alan K. Meeker, Michael Torbenson

    Izdano 2013
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  15. 15
    Neuroendocrine Liver Metastasis Treated by Using Intraarterial Therapy: Volumetric Functional Imaging Biomarkers of Early Tumor Response and Survival

    Neuroendocrine Liver Metastasis Treated by Using Intraarterial Therapy: Volumetric Functional Imaging Biomarkers of Early Tumor Response and Survival od Vivek Gowdra Halappa, Celia P. Corona‐Villalobos, Susanne Bonekamp, Zhen Li, Diane K. Reyes, David Cosgrove, Timothy M. Pawlik, Luis A. Díaz, Nikhil Bhagat, John Eng, Jean-François H. Geschwind, Ihab R. Kamel

    Izdano 2012
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  16. 16
    Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors

    Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors od Edward A. Sausville, Patricia LoRusso, Michael A. Carducci, Judith Carter, Mary Flanagan Quinn, Lisa Malburg, Nilofer S. Azad, David Cosgrove, Richard Knight, Peter Barker, Sonya Zabludoff, Felix Agbo, Patricia Oakes, Adrian M. Senderowicz

    Izdano 2014
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  17. 17
    A phase I trial of vertical inhibition of IGF signalling using cixutumumab, an anti-IGF-1R antibody, and selumetinib, an MEK 1/2 inhibitor, in advanced solid tumours

    A phase I trial of vertical inhibition of IGF signalling using cixutumumab, an anti-IGF-1R antibody, and selumetinib, an MEK 1/2 inhibitor, in advanced solid tumours od Breelyn A. Wilky, Michelle A. Rudek, Shabina Roohi Ahmed, Dan Laheru, David Cosgrove, Ross C. Donehower, Barry D. Nelkin, Douglas W. Ball, L. Austin Doyle, H Chen, X Ye, Graham Bigley, Chris Womack, Nilofer S. Azad

    Izdano 2014
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  18. 18
    TheraSphere Yttrium-90 Glass Microspheres Combined With Chemotherapy Versus Chemotherapy Alone in Second-Line Treatment of Patients With Metastatic Colorectal Carcinoma of the Liver: Protocol for the EPOCH Phase 3 Randomized Clinical Trial

    TheraSphere Yttrium-90 Glass Microspheres Combined With Chemotherapy Versus Chemotherapy Alone in Second-Line Treatment of Patients With Metastatic Colorectal Carcinoma of the Live... od Nikhil Chauhan, Mary F. Mulcahy, Riad Salem, Al B. Benson, Éveline Boucher, Janet Bukovcan, David Cosgrove, Chantal Laframboise, Robert J. Lewandowski, Fayaz Master, Bassel F. El‐Rayes, Jonathan Strosberg, Daniel Y. Sze, Ricky A. Sharma

    Izdano 2019
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  19. 19
    Diffuse Infiltrative Hepatocellular Carcinoma: Assessment of Presentation, Treatment, and Outcomes

    Diffuse Infiltrative Hepatocellular Carcinoma: Assessment of Presentation, Treatment, and Outcomes od Peter J. Kneuertz, Aram N. Demirjian, Amin Firoozmand, Celia P. Corona‐Villalobos, Nikhil Bhagat, Joseph M. Herman, Andrew M. Cameron, Ahmet Gürakar, David Cosgrove, Michael A. Choti, Jean-François H. Geschwind, Ihab R. Kamel, Timothy M. Pawlik

    Izdano 2012
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  20. 20
    Knock in of the AKT1 E17K mutation in human breast epithelial cells does not recapitulate oncogenic PIK3CA mutations

    Knock in of the AKT1 E17K mutation in human breast epithelial cells does not recapitulate oncogenic PIK3CA mutations od Josh Lauring, David Cosgrove, Stefani C. Fontana, John P. Gustin, Hiroyuki Konishi, Abde M. Abukhdeir, Joseph P. Garay, Morassa Mohseni, Guoli Wang, Michaela J. Higgins, David U. Gorkin, Marcelo Reis, Bert Vogelstein, Kornélia Polyák, Marianne Cowherd, Phillip Buckhaults, B H Park

    Izdano 2010
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: